Suramin, an anti-cancer drug, inhibits protein kinase C and induces differentiation in neuroblastoma cell clone NB2A

FEBS Letters

Volumn 258, Issue 1, 1989, Pages 156-158

  Hensey, Carmel E ^a   Boscoboinik, Daniel ^a   Azzi, Angelo ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Antineoplastic therapy; Differentiation; Neuroblastoma; Proliferation inhibition; Protein kinase C; Suramin

Indexed keywords

PROTEIN KINASE C; SURAMIN;

ANTINEOPLASTIC ACTIVITY; CELL CULTURE; CELL DIFFERENTIATION; ENZYME INHIBITION; GROWTH INHIBITION; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL;

ANIMAL; ANTINEOPLASTIC AGENTS; BRAIN; CELL DIFFERENTIATION; CELL DIVISION; CELL SURVIVAL; MICE; NEUROBLASTOMA; PROTEIN KINASE C; RATS; SUPPORT, NON-U.S. GOV'T; SURAMIN; TUMOR CELLS, CULTURED;

EID: 0024461389     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-5793(89)81639-4     Document Type: Article

References (14)

1. Isolation of a homogeneous lysine-rich histone from calf thymus
2. Suramin: A potent ATPase inhibitor which acts on the inside surface of the sodium pump